NYKODE THERAPEUTICS ASA financial statements, including revenue, expenses, profit, and loss
The total revenue of NYKD for the last quarter is 23.74 M NOK, and it's 17.95% lower compared to the previous quarter. The net income of Q4 23 is -57.84 M NOK.